A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients.
DiPeri TP, Newhook TE, Day RW, Chiang YJ, Dewhurst WL, Arvide EM, Bruno ML, Scally CP, Roland CL, Katz MHG, Vauthey JN, Chang GJ, Badgwell BD, Perrier ND, Grubbs EG, Lee JE, Tzeng CD; PROMOTE Consortium.
DiPeri TP, et al.
Surg Open Sci. 2022 Apr 25;9:51-57. doi: 10.1016/j.sopen.2022.04.004. eCollection 2022 Jul.
Surg Open Sci. 2022.
PMID: 35663797
Free PMC article.